Tandem Diabetes Care (TNDM) Change in Inventory (2013 - 2026)
Tandem Diabetes Care (TNDM) posted Change in Inventory of -$1.9 million for Q1 2026, up 74.52% on a QoQ basis from -$7.6 million in Q4 2025, and up 79.93% year-over-year from -$1.1 million in Q1 2025.
Tandem Diabetes Care (TNDM) Change in Inventory (2013 - 2026) Analysis & Trends
Tandem Diabetes Care's Change in Inventory history runs 14 years deep, the most recent figure standing at -$1.9 million for Q1 2026.
- Quarterly Change in Inventory rose 79.93% year-over-year to -$1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$17.1 million (down 39.89% YoY) and the FY2025 annual result came in at -$24.8 million, down 327.13% from the prior year.
- Change in Inventory was -$1.9 million for Q1 2026 at Tandem Diabetes Care, up from -$7.6 million in the prior quarter.
- Across five years, Change in Inventory topped out at $19.9 million in Q1 2023 and bottomed at -$10.4 million in Q3 2024.
- A 5-year average of $3.3 million and a median of -$595000.0 in 2024 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2022 — Change in Inventory soared 7149.58% — and 2025, when it sank 1171.26%.
- Tandem Diabetes Care's Change in Inventory stood at $5.4 million in 2022, then jumped by 147.48% to $13.3 million in 2023, then sank by 104.46% to -$595000.0 in 2024, then sank by 1171.26% to -$7.6 million in 2025, then surged by 74.52% to -$1.9 million in 2026.
- Business Quant data shows TNDM's Change in Inventory at -$1.9 million in Q1 2026, -$7.6 million in Q4 2025, and -$5.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn | 420.00 Mn |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn | 127.00 Mn |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn | -399.00 Mn |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn | 1.60 Mn |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn | 65.20 Mn |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn | 171.00 Mn |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | -264.59 Mn |
| 10 | Tandem Diabetes Care | 1.15 Bn | 582.17 Mn | 136.79 Mn | -1.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.93 Mn |
| Mar 31, 2026 | -1.93 Mn |
| Dec 31, 2025 | -7.56 Mn |
| Dec 31, 2025 | -7.56 Mn |
| Sep 30, 2025 | -5.19 Mn |
| Sep 30, 2025 | -5.19 Mn |
| Jun 30, 2025 | -2.46 Mn |
| Jun 30, 2025 | -2.46 Mn |
| Mar 31, 2025 | -9.60 Mn |
| Mar 31, 2025 | -9.60 Mn |
| Dec 31, 2024 | -595,000.00 |
| Dec 31, 2024 | -595,000.00 |
| Sep 30, 2024 | -10.37 Mn |
| Sep 30, 2024 | -10.37 Mn |
| Jun 30, 2024 | 8.31 Mn |
| Jun 30, 2024 | 8.31 Mn |
| Mar 31, 2024 | -3.16 Mn |
| Mar 31, 2024 | -3.16 Mn |
| Dec 31, 2023 | 13.34 Mn |
| Dec 31, 2023 | 13.34 Mn |